Skip to main content

Table 3 Bivariate and multivariate analysis for patient related risk factors for any drug resistance among pulmonary TB patients attending two public hospitals in East Gojjam zone, northwest Ethiopia (n = 89)

From: Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia

Characteristic

Any drug resistance

COR (95 % CI)

P-value

AOR (95 % CI)

p-value

Yes, n (%)

No, n (%)

Sex

    

Male

13 (72.2)

45 (63.4)

1.52 (0.48-4.69)

0.48

  

Female

5 (27.8)

26 (36.6)

    

HIV-status

HIV-positive

6 (33.3)

11 (15.5)

2.72 (0.85-8.81)

0.093

2.76 (0.72-10.54)

0.14

HIV-negative

12 (66.7)

60 (84.5)

    

Age group (in years)

15-24

4 (22.2)

28 (39.4)

    

25-34

10 (55.6)

15 (21.1)

4.67 (1.25-17.44)

0.022

4.24 (1.02-17.5)

0.046

35-44

3 (16.6)

17 (23.9)

1.24 (0.25-6.21)

0.79

0.99 (0.18-5.65)

0.99

≥45

1 (5.6)

11 (15.6)

0.64 (0.064-6.35)

0.71

0.59 (0.05-6.36)

0.66

Previous history of treatment

Yes

6 (33.3)

6 (8.4)

5.42 (1.49-19.64)

0.01

6.55 (1.56-27.49)

0.01

No

12 (66.7)

65 (91.6)

    

Smear microscopy

 

Smear-positive

12 (66.7)

46 (64.8)

1.087 (0.36-3.24)

0.88

  

Smear-negative

6 (33.3)

25 (35.2)

    
  1. AOR, Adjusted Odds Ratio; HIV, Human Immunodeficiency Virus; CI, Confidence Interval, COR, Crude Odds Ratio